Bioactive Glass S53P4 in Mastoid Obliteration Surgery for Chronic Otitis Media and Cerebrospinal Fluid Leakage

Mudry A . History of instruments used for mastoidectomy. J Laryngol Otol 2009;123:583–9.

Palva T . Operative technique in mastoid obliteration. Acta Otolaryngol 1973;75:289–90.

Gantz BJ Wilkinson EP Hansen MR . Canal wall reconstruction tympanomastoidectomy with mastoid obliteration. Laryngoscope 2005;115:1734–40.

Bennett M Warren F Haynes D . Indications and technique in mastoidectomy. Otolaryngol Clin North Am 2006;39:1095–113.

Nadol JB Jr . Revision mastoidectomy. Otolaryngol Clin North Am 2006;39:723–40,vi–vii.

Mehta RP Harris JP . Mastoid obliteration. Otolaryngol Clin North Am 2006;39:1129–42.

Jang CH . Changes in external ear resonance after mastoidectomy: Open cavity mastoid versus obliterated mastoid cavity. Clin Otolaryngol Allied Sci 2002;27:509–11.

Ramsey MJ Merchant SN McKenna MJ . Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Otol Neurotol 2004;25:873–8.

Singh V Atlas M . Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap. Otolaryngol Head Neck Surg 2007;137:433–8.

Irving RM Gray RF Moffat DA . Bone pâté obliteration or revision mastoidectomy: A five-symptom comparative study. Clin Otolaryngol Allied Sci 1994;19:158–60.

Dornhoffer JL . Surgical modification of the difficult mastoid cavity. Otolaryngol Head Neck Surg 1999;120:361–7.

Lee WS Choi JY Song MH Son EJ Jung SH Kim SH . Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket. Otol Neurotol 2005;26:1107–11.

Leatherman BD Dornhoffer JL . The use of demineralized bone matrix for mastoid cavity obliteration. Otol Neurotol 2004;25:22–6.

Lee WS Kim SH Lee WS Kim SH Moon IS Byeon HK . Canal wall reconstruction and mastoid obliteration in canal wall down tympanomastoidectomized patients. Acta Otolaryngol 2009;129:955–61.

Mahendran S Yung MW . Mastoid obliteration with hydroxyapatite cement: The Ipswich experience. Otol Neurotol 2004;25:19–21.

Stoor P Pulkkinen J Grénman R . Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol 2010;119:377–82.

Linthicum FH Jr . The fate of mastoid obliteration tissue: A histopathological study. Laryngoscope 2002;112:1777–81.

Ridenour JS Poe DS Roberson DW . Complications with hydroxyapatite cement in mastoid cavity obliteration. Otolaryngol Head Neck Surg 2008;139:641–5.

Rahaman MN Day DE Bal BS . Bioactive glass in tissue engineering. Acta Biomater 2011;7:2355–73.

Jang CH Cho YB Bae CS . Evaluation of bioactive glass for mastoid obliteration: A guinea pig model. In Vivo 2007;21:651–5.

Wilson J Pigott GH Schoen FJ Hench LL . Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981;15:805–17.

Stoor P Söderling E Salonen JI . Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998;56:161–5.

Stoor P Söderling E Grenman R . Interactions between the bioactive glass S53P4 and the atrophic rhinitis–associated microorganism Klebsiella ozaenae. J Biomed Mater Res 1999;48:869–74.

Stoor P Söderling E Grénman R . Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection–associated microorganisms Haemophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res 2001;58:113–20.

Munukka E Leppäranta O Korkeamäki M . Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med 2008;19:27–32.

Leppäranta O Vaahtio M Peltola T . Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med 2008;19:547–51.

Zhang D Leppäranta O Munukka E . Antibacterial effects and dissolution behavior of six bioactive glasses. J Biomed Mater Res A 2010;93:475–83.

Peltola M Kinnunen I Aitasalo K . Reconstruction of orbital wall defects with bioactive glass plates. J Oral Maxillofac Surg 2008;66:639–46.

Kos MI Castrillon R Montandon P Guyot JP . Anatomic and functional long-term results of canal wall–down mastoidectomy. Ann Otol Rhinol Laryngol 2004;113:872–6.

Dornhoffer JL Smith J Richter G Boeckmann J . Impact on quality of life after mastoid obliteration. Laryngoscope 2008;118:1427–32.

Santina CC Della Lee SC . Ceravital reconstruction of canal wall down mastoidectomy: Long-term results. Arch Otolaryngol Head Neck Surg 2006;132:617–23.

Stow NW Gordon DH Eisenberg R . Technique of temporoparietal fascia flap in ear and lateral skull base surgery. Otol Neurotol 2010;31:964–7.

Abdel-Rahman AM Pietola M Kinnari TJ Ramsay H Jero J Aarnisalo AA . Obliteration of radical cavities with autogenous cortical bone; long-term results. BMC Ear Nose Throat Disord 2008;8:4.

Mokbel KM Khafagy YW . Single flap with three pedicles, bone paté and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy. Eur Arch Otorhinolaryngol 2011 Nov 30 [Epub ahead of print].

Lindfors NC Hyvönen P Nyyssönen M . Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010;47:212–8.

Bizakis JG Chimona TS Hajiioannou JK . Canal wall down mastoidectomy for cholesteatoma: Experience at the University of Crete. J Otolaryngol 2006;35:48–52.

Aitasalo KM Peltola MJ . Bioactive glass hydroxyapatite in fronto-orbital defect reconstruction. Plast Reconstr Surg 2007;120:1963–74.

Peltola MJ Aitasalo KM Aho AJ Tirri T Suonpää JT . Long-term microscopic and tissue analytical findings for 2 frontal sinus obliteration materials. J Oral Maxillofac Surg 2008;66:1699–707.